What is KMTS's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 1.62B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for KMTS?

P/E (TTM) is n/a and 52-week range is $17.34 to $30.00 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s KMTS figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for KMTS?

The company profile lists revenue (TTM) near $107M, net income (TTM) near $-15.00B, EPS (TTM) near $-2.67 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Kestra Medical Technologies Ltd based, and what identifiers does Chartloom list?

The company context section lists headquarters in Kirkland, Washington, US, 58.6M shares outstanding, ISIN BMG524411052 when available from company profile and filing metadata.

Free AI scores & summaries library

Kestra Medical Technologies Ltd

$KMTS

Health Care · Health Care Equipment & Supplies

Run Scenarios

$27.24

-5.02%

Free AI scores & summaries library

Kestra Medical Technologies Ltd

$KMTS

Health Care · Health Care Equipment & Supplies

Run Scenarios

$27.24

-5.02%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Kestra Medical Technologies Ltd. is a commercial-stage, wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington and currently employs 330 full-time employees. The company went IPO on 2025-03-06. The firm has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The firm's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.

Employees

330

IPO

2025-03-06

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (TTM)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

NASDAQ NMS - GLOBAL MARKET

ISIN

BMG524411052

Headquarters

Kirkland, Washington, US

Shares outstanding

58.6M

NAICS sector

Manufacturing

Institutional ownership

55.61%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Kestra Medical Technologies Ltd. is a commercial-stage, wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington and currently employs 330 full-time employees. The company went IPO on 2025-03-06. The firm has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The firm's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.

Employees

330

IPO

2025-03-06

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)